Pilot Cohorts for Development of Concurrent Mobile Treatment for Alcohol and Tobacco Use Disorders.

dc.contributor.author

Medenblik, Alyssa M

dc.contributor.author

Calhoun, Patrick S

dc.contributor.author

Maisto, Stephen A

dc.contributor.author

Kivlahan, Daniel R

dc.contributor.author

Moore, Scott D

dc.contributor.author

Beckham, Jean C

dc.contributor.author

Wilson, Sarah M

dc.contributor.author

Blalock, Dan V

dc.contributor.author

Dedert, Eric A

dc.date.accessioned

2021-09-30T19:23:02Z

dc.date.available

2021-09-30T19:23:02Z

dc.date.issued

2021-01

dc.date.updated

2021-09-30T19:23:01Z

dc.description.abstract

Alcohol and tobacco are the 2 most frequently used drugs in the United States and represent the highest co-occurrence of polysubstance use. The objective of this study was to refine an intervention combining mobile contingency management with cognitive-behavioral telephone counseling for concurrent treatment of alcohol and tobacco use disorders. Two cohorts (n = 13 total, n = 5 women) of participants were enrolled, with 10/13 completing treatment and 7/13 completing the 6-month follow-up. At enrollment, participants were drinking a mean of 28.9 drinks per week (SD = 14.1), with a mean of 14.7 heavy drinking days in the past month (SD = 9.9), and a mean of 18.1 cigarettes per day (SD = 11.7). Treatment included a mobile application that participants used to record carbon monoxide and breath alcohol content readings to bioverify abstinence. Participants received up to 4 sessions of phone cognitive-behavioral therapy and monetary reinforcement contingent on abstinence. In cohort 1, 4/6 participants reported abstinent or low-risk drinking post-monitoring. Six weeks post quit-date, 2/6 participants were CO-bioverified abstinent from tobacco use, with 2/6 in dual remission. These results were maintained at 6-months. In cohort 2, 6/7 reported abstinent or low-risk drinking post-monitoring, 5 weeks post quit-date. At the post-monitoring visit, 5/7 were CO-bioverified abstinent from smoking, with 5/7 in dual remission. At 6-months, 3/7 reporting abstinent or low-risk drinking, 1/7 had bioverified abstinence from smoking, with 1/7 in dual remission. Observations suggest that it is possible to develop a concurrent mobile treatment for alcohol and tobacco use disorders.

dc.identifier

10.1177_11782218211030524

dc.identifier.issn

1178-2218

dc.identifier.issn

1178-2218

dc.identifier.uri

https://hdl.handle.net/10161/23862

dc.language

eng

dc.publisher

SAGE Publications

dc.relation.ispartof

Substance abuse : research and treatment

dc.relation.isversionof

10.1177/11782218211030524

dc.subject

Alcohol

dc.subject

cognitive behavioral therapy

dc.subject

comorbidity

dc.subject

contingency management

dc.subject

tobacco

dc.title

Pilot Cohorts for Development of Concurrent Mobile Treatment for Alcohol and Tobacco Use Disorders.

dc.type

Journal article

duke.contributor.orcid

Beckham, Jean C|0000-0001-8746-8949

duke.contributor.orcid

Wilson, Sarah M|0000-0002-1028-6028

duke.contributor.orcid

Blalock, Dan V|0000-0002-8349-9825

duke.contributor.orcid

Dedert, Eric A|0000-0003-1301-7058

pubs.begin-page

11782218211030524

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Duke Institute for Brain Sciences

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Basic Science Departments

pubs.publication-status

Published

pubs.volume

15

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pilot Cohorts for Development of Concurrent Mobile Treatment for Alcohol and Tobacco Use Disorders.pdf
Size:
935.39 KB
Format:
Adobe Portable Document Format
Description:
Accepted version